Case Based Peer Perspectives

David Zhen, MD, reviews the case of a 60-year-old man with stage IV gastric adenocarcinoma and discusses ongoing research and the evolving treatment landscape.

Sandip P. Patel, MD, a medical oncologist, reviews the case of a 60-year-old woman with early-stage non–small cell lung cancer and provides clinical insights on treatment practices.

Lori Wirth, MD, reviews the case of a 64-year-old woman with differentiated thyroid cancer (DTC) and provides clinical insights on the treatment landscape for patients with radioiodine-refractory disease.

Expert Matthew Lunning, DO, FACP, reviews the case of a 73-year-old woman with R/R DLBCL, considering current and emerging treatment strategies in this setting.

Michael B Atkins, MD, discusses first-line treatment options for a patient with stage IV BRAF-mutated melanoma. He also reviews data that may help guide treatment and sequencing decisions for patients with metastatic melanoma.

Joshua K. Sabari, MD, reviews the case of a 73-year-old with EGFR+ non–small cell lung cancer and provides comprehensive insights on the evolving treatment landscape.

Justin LaPorte, PharmD, BCOP, discusses the administration of bispecific antibodies and the coordination between academic and community centers.

Expert Matthew Lunning, DO, FACP, reviews the case of a 67-year-old man with R/R DLBCL and considers optimal treatment strategies in this setting.

Anthony Hunter, MD, presents the case of a 76-year-old woman with newly diagnosed myelofibrosis for discussion and reviews the available treatment options, including the recently FDA approved JAK inhibitor momelotinib.

Matthew L. Ulrickson, MD, discusses the diagnosis, treatment, and future therapeutic landscape of relapsed/refractory BPDCN, addressing unmet needs and promising therapies in this rare disease.

Rafael Fonseca, MD, discusses treatment considerations for a 66-year-old man with relapsed/refractory multiple myeloma after several prior therapies, and highlights recent clinical trial results with novel BCMA-targeted bispecific antibodies and other therapies in the relapsed/refractory setting.

Centering discussion on a patient case of relapsed/refractory multiple myeloma, expert David Dingli, MD, PhD, reflects on the current treatment paradigm and evolving management strategies in this setting.

Expert Matthew Lunning, DO, FACP, reviews a patient case of diffuse large b-cell lymphoma and considers how the evolving treatment paradigm has impacted clinical practice.

Expert insight into optimal diagnosis and management strategies for blastic plasmacytoid dendritic cell neoplasm (BPDCN) centered around a hypothetical patient case.

Centering discussion on a patient case of metastatic non–small cell lung cancer, expert Sandip P. Patel, MD, provides insight into updated research and treatment strategies with immunotherapeutic and targeted agents.

Expert gynecologic oncologist Ramez N. Eskander, MD, reviews the diagnosis and management of a 67-year-old woman with metastatic cervical cancer.

Hussein Tawbi, MD, PhD, discusses recent study updates and advances in the treatment of melanoma through the context of two patient cases.

Ajai Chari, MD, presents the case of a woman with relapsed/refractory multiple myeloma and discusses the available treatment options for patients with more than 4 prior lines of therapy, referencing recent key clinical trial data.

An expert oncologist reviews a patient case of metastatic urothelial carcinoma and provides insights on the latest treatment updates in targeted therapy.

Aaron T. Gerds, MD, MS, provides an overview of the currently available and emerging treatment options for patients with myelofibrosis.

Jamie L. Koprivnikar, MD, presents the case of a 72-year-old woman with single lineage dysplasia myelodysplastic syndrome, reviews the typical treatment approaches, and shares key data from a subgroup analysis of the COMMANDS trial presented at the ASCO and EHA 2023 Annual Meetings.

Chad A. Hamilton, MD, reviews the case of a 49-year-old woman with BRCA wild-type ovarian cancer and offers clinical insights on molecular testing practices, PARP inhibitors, and the evolving treatment landscape.

Daniel J. George, MD, presents the case of a 65-year-old man with prostate cancer, reviews recent clinical trial data, and discusses his treatment practices.

Amy Dezern, MD, MHS, presents the case of a 70-year-old man with myelodysplastic syndrome (MDS) and low ISSP-R, and reviews the best approaches for treatment of similar patients in clinical practice.

Ritu Salani, MD, reviews the case of a patient with cervical cancer and offers clinical insights on treatment, prevention, and the research landscape.

Key opinion leader Andrew Lipsky, MD, reviews the case of a 72-year-old man with relapsed/refractory chronic lymphocytic leukemia and highlights the evolving treatment landscape of targeted therapy in this setting.

Expert perspectives on the current treatment paradigm for patients diagnosed with locally advanced or metastatic urothelial carcinoma.

Leslie Randall, MD, MAS, presents the case of a patient with BRCA-mutated ovarian cancer and provides insights on the evolving treatment landscape.

Expert oncologist Alicia Morgans, MD, MPH, reviews the case of a 75-year-old man with metastatic castration-resistant prostate cancer and discusses appropriate treatment strategies in this setting.

Melissa Alsina, MD introduces the case of a patient with newly diagnosed multiple myeloma, discusses best practices for treating transplant-not-preferred patients, and engages with emergent trial data.